共 36 条
[1]
Siami S., Annane D., Sharshar T., The encephalopathy in sepsis, Crit Care Clin, 24, pp. 67-82, (2008)
[2]
Ely E.W., Gautam S., Margolin R., Et al., The impact of delirium in the intensive care unit on hospital length of stay, Intensive Care Med, 27, pp. 1892-1900, (2001)
[3]
Sonneville R., Verdonk F., Rauturier C., Et al., Understanding brain dysfunction in sepsis, Ann Intensive Care, 3, (2013)
[4]
Charchaflieh J., Rushbrook J., Worah S., Zhang M., Activated complement factors as disease markers for sepsis, Dis Markers, 2015, (2015)
[5]
Flierl M.A., Stahel P.F., Rittirsch D., Et al., Inhibition of complement C5a prevents breakdown of the blood–brain barrier and pituitary dysfunction in experimental sepsis, Crit Care, 13, 1, (2009)
[6]
Esen F., Senturk E., Ozcan P.E., Et al., Intravenous immunoglobulins prevent the breakdown of the blood–brain barrier in experimentally induced sepsis, Crit Care Med, 40, pp. 1214-1220, (2012)
[7]
Ritter C., Andrades M., Frota Junior M.L., Et al., Oxidative parameters and mortality in sepsis induced by cecal ligation and perforation, Intensive Care Med, 29, pp. 1782-1789, (2003)
[8]
Tuzun E., Zhou L., Baehring J.M., Bannykh S., Rosenfeld M.R., Dalmau J., Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma, Acta Neuropathol, 118, pp. 737-743, (2009)
[9]
Dalakas M.C., Mechanistic effects of IVIg in neuroinflammatory diseases: conclusions based on clinicopathologic correlations, J Clin Immunol, 34, pp. S120-S126, (2014)
[10]
Relkin N., Intravenous immunoglobulin for Alzheimer’s disease, Clin Exp Immunol, 178, pp. 27-29, (2014)